Table 1.

GNPs modified with FDG-related molecules for biomedical applications.

Author	GNPs Surface Agent	Target	Biomedical Application
Roa et al. (2012) [72]	6-fluoro-6-deoxy-D-glucose	Breast adenocarcinoma	Radiosensitizer
Suvarna et al. (2017) [70]	2-deoxy-D-glucose	cancer cell lines such as HepG2, HeLa and HCT 116	Theragnostic
Hu et al. (2015) [47]	Glucose-coating	Breast adenocarcinoma	Radiosensitizer
Jiang et al. (2014) [69]	PEGylation + 2-deoxy-D-glucose	Brain glioma	Drug-delivery
Unak et al. (2012) [71]	18F-2-fluoro-2-deoxy-D-glucose + Ab anti-metadherin (MTDH)	Breast adenocarcinoma	Theragnostic
Feng et al. (2014) [74]	PEGylation + glucose-coating	BALB/c nude mice	CT imaging contrast agent
Hu et al. (2015) [47]	Glucose-coating	Leukemic stem cell line THP-1 and breast cell line MCF-7	Radiosensitizer